Cho Farma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 22-12-2024
- Paid Up Capital ₹ 0.50 M
as on 22-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 16.67%
(FY 2022)
- Profit -9.65%
(FY 2022)
- Ebitda -20.09%
(FY 2022)
- Net Worth 10.56%
(FY 2022)
- Total Assets 5.39%
(FY 2022)
About Cho Farma
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Channayya Masaguppimath, Mallappa Katti, Praveen Katti, and Two other members serve as directors at the Company.
- CIN/LLPIN
U01110KA2017PTC101824
- Company No.
101824
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bagalkot, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cho Farma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mallappa Katti  | Managing Director | 29-Mar-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Channayya Masaguppimath | Director | 29-Mar-2017 | Current |
| Praveen Katti | Director | 29-Mar-2017 | Current |
| Vinod Katti | Director | 29-Mar-2017 | Current |
| Katti Mallappa | Director | 29-Mar-2017 | Current |
Financial Performance of Cho Farma.
Cho Farma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.67% increase. The company also saw a slight decrease in profitability, with a 9.65% decrease in profit. The company's net worth Soared by an impressive increase of 10.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cho Farma?
Unlock access to Cho Farma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rohini Bio-Chem Microinputs Private LimitedActive 13 years 4 monthsChannayya Masaguppimath, Mallappa Katti and 3 more are mutual person
Kisaancare Horticultural Farmers Producer Company LimitedActive 2 years 11 monthsPraveen Katti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cho Farma?
Unlock and access historical data on people associated with Cho Farma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cho Farma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cho Farma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.